Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic strategies targeting pro-fibrotic macrophages in interstitial lung disease
Takuma Isshiki, Megan Vierhout, Safaa Naiel, et al.
Biochemical Pharmacology (2023) Vol. 211, pp. 115501-115501
Closed Access | Times Cited: 13

Showing 13 citing articles:

Macrophage Implication in IPF: Updates on Immune, Epigenetic, and Metabolic Pathways
Deepak Pokhreal, Bruno Crestani, Doumet Georges Helou
Cells (2023) Vol. 12, Iss. 17, pp. 2193-2193
Open Access | Times Cited: 15
Autologous precision-cut lung slice co-culture models for studying macrophage-driven fibrosis
So-Yi Chang, Wen‐Hsin Chang, David C.H. Yang, et al.
Frontiers in Physiology (2025) Vol. 16
Open Access
Reducing M2 macrophage in lung fibrosis by controlling anti-M1 agent
Fatemeh Bahram Yazdroudi, Alaeddin Malek
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
CC-chemokine ligand 18, CXC motif chemokine 13 and osteopontin as biomarkers of silicosis and asbestosis: a prospective observational study
Na Wu, Changjiang Xue, Shiwen Yu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Favipiravir ameliorates bleomycin-induced pulmonary fibrosis by reprogramming M1/M2 macrophage polarization
Ruiqin Zhang, Qiuyan Jiang, Shaoyan Gao, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111774-111774
Closed Access | Times Cited: 4
Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders
Sumel Ashique, Neeraj Mishra, Shubhrajit Mantry, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 4
Up-regulated SPP1 increases the risk from IPF to lung cancer via activating the pro-tumor macrophages
Tingting Chen, Jiayu Guo, Liqiang Ai, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 5751-5764
Open Access | Times Cited: 5
SGK1 aggravates idiopathic pulmonary fibrosis by triggering H3k27ac-mediated macrophage reprogramming and disturbing immune homeostasis
Jianzhi Wu, Liping Gong, Yijie Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 3, pp. 968-986
Open Access | Times Cited: 1
The IL-4/13-induced production of M2 chemokines by human lung macrophages is enhanced by adenosine and PGE2
Marion Brollo, Hélène Salvator, Stanislas Grassin‐Delyle, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111557-111557
Open Access | Times Cited: 1
Cepharanthine attenuates pulmonary fibrosis via modulating macrophage M2 polarization
Jiaqi Bao, Chang Liu, Huafeng Song, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Macrophages in Lung Repair and Fibrosis
Yago Amigo Pinho Jannini de Sá, Brecht Creyns, Cory M. Hogaboam, et al.
Results and problems in cell differentiation (2024), pp. 257-290
Closed Access | Times Cited: 1
Mechanisms underlying the involvement of peritoneal macrophages in the pathogenesis and novel therapeutic strategies for dialysis-induced peritoneal fibrosis
Yangwei Wang, Yixian Zhang, Mingqi Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Predominance of M2 macrophages in organized thrombi in chronic thromboembolic pulmonary hypertension patients
Thomas Koudstaal, Thierry van den Bosch, Ingrid M. Bergen, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 6
Open Access
Page 1

Scroll to top